SCHEMBL17151122

SCHEMBL17151122

Cc1nnc(C(C)(F)F)cc1CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17151126 0.81 MEN1 (0.33) —
SCHEMBL15633406 0.77 — —
SCHEMBL11321780 0.71 KMT2A (0.32) —
SCHEMBL18998281 0.70 KMT2A (0.35) —
SCHEMBL17773649 0.64 ALDH1A1 (0.31) —
SCHEMBL4168090 0.64 KMT2A (0.39) —
SCHEMBL29403057 0.63 PTGS2 (0.36) —
SCHEMBL17816254 0.63 — —
SCHEMBL16481518 0.62 GABRB3 (0.36) —
SCHEMBL15633519 0.61 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015153304-A1 PRODRUGS OF HIV REVERSE TRANSCRIPTASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-10-08 — — WO disclosed
Send feedback